Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla US...

FDA Recall #D-0043-2025 — Class II — October 23, 2024

Recall #D-0043-2025 Date: October 23, 2024 Classification: Class II Status: Ongoing

Product Description

Lanthanum Carbonate Chewable Tablets, 1000mg, 10-count bottle, Rx only, Manufactured for Cipla USA, NDC 69097-0936-98

Reason for Recall

Failed Tablet/Capsule Specifications: Complaints received of crushed and broken tablets.

Recalling Firm

Cipla USA, Inc. — Warren, NJ

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1,875 boxes (cipla and exlan)

Distribution

USA nationwide.

Code Information

Lot # NB240316, Exp 12/31/25

Status

Ongoing

Voluntary / Mandated

Voluntary: Firm initiated

What Should You Do?

Stop using this medication immediately and contact your pharmacist or doctor. Do not flush medications down the drain. Return the product to the place of purchase for a refund or replacement.

Back to All Drug Recalls